The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I was a LTH of SCIR/SOLO but sold up 2 years ago (big loss) after One Dyas deal fell through.
Just a thought concerning RNS on the 13th.
Quote
Those Directors who hold shares, representing 3.2% of the Company's issued share capital, believe the Proposed Transaction to be in the best interests of the Company and will be voting in favour at the General Meeting which states following:
· In addition the Company has received letters of support for the Proposed Transaction from significant shareholders representing 11.1% of the Company's issued share capital which confirm that it is their current intention to vote in favour of the resolution at the General Meeting
Unquote
So who are these 11.1% of shareholders who had information prior to release of RNS. Seems to me it’s not a level playing field for other shareholders. Is not such a proposed deal possibly share price sensitive and therefore should be released to all shareholders at the same time? Wonder what UKLA ( or whatever it’s called these days) would think.
That’s all.
Good luck to you all and hope you achieve the outcome in your best interests.
Had enough after maybe 8 years and 70% loss. Life’s too short so I’ve sold my last % holding here today and moved on. Still got some AEX and have a decent holding in HE1.
Can’t understand why BDS1 and Caddy continually make negative posts yet still hold. Get a life guys!
Good luck and hope you come good with SCIR eventually.
Thanks PeterAB, I’ll take a look later. So for Fitzy to realise around £220k SP would need to hit 3p?
Thanks CP. Yes 1.3p does seem to suggest that BOD expectations are quite low, either that or they are just plain greedy and taking the p*ss out of shareholders. FWIW I would vote against such proposal on that basis.
Remuneration not renumeration.....
Peterashbeck. Thanks for taking trouble to reply. I’m trying to form an opinion as to whether the incentive awards are fair or not. Every one to their own opinion of course. I guess short term holders who are holding with average of 1p could accept a low strike price whereas long termers like me would think a higher strike price fairer.
I didn’t want to trawl through historical RNSs but does anyone know roughly what kind of renumeration Solo directors have been receiving previously?
Thanks R
Morning
Not sure if my understanding of yesterday’s RNS is correct so I am checking with the experts on this BB. My understanding is that the directors have been awarded options which gives them the right to buy newly issued shares at 1.3p sometime between now and June 21. Therefore if share price hits 3p during this period they could exercise the option by purchasing the shares and then sell them in the market for 3p and make 1.7p profit per share. If price does not hit at least 1.3p by Jun 21 then shares would expire worthless and poor directors would not receive a bean.
Also why are 2 amounts mentioned on each dealing form except the form for Ferguson which indicates the number of options (12m) and the number of free shares (7.5m) which is his bonus for all the hard work he has put in in achieving nothing. Not denying he may have worked hard but end of the day the market went against him end result is back to square one.
R
Cheers
If Solo had concluded the 1D deal 2 or 3 months earlier and everything was signed off we could be in a right old mess now......every cloud as they say.
My concern also. I hope they are not going to shaft the LTHs.
I don’t think it’s your plaice to make such accusations OG.